These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 3156701)

  • 1. Chronic myelocytic leukaemia: HLA association and decreased erythrocyte C3b receptor expression.
    Ruuska P; Silvennoinen-Kassinen S; Timonen T; Tiilikainen A
    Clin Exp Immunol; 1985 Feb; 59(2):300-4. PubMed ID: 3156701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defective erythrocyte C3b receptor function associated with low serum complement (C3, C4) concentrations in insulin-dependent diabetes mellitus.
    Ruuska P; Ilonen J; Mustonen A; Tiilikainen A
    Clin Exp Immunol; 1984 Jul; 57(1):12-6. PubMed ID: 6235073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Association between HLA antigens and leukemia in the population of Vojvodina].
    Vojvodić S; Belić B; Popović S
    Med Pregl; 2001; 54(3-4):128-34. PubMed ID: 11759203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA system affects the age-at-onset in chronic myeloid leukemia.
    Oguz FS; Kalayoglu S; Diler AS; Tozkir H; Sargin D; Carin M; Dorak MT
    Am J Hematol; 2003 Aug; 73(4):256-62. PubMed ID: 12879429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunophenotypic and HLA studies in childhood acute lymphoblastic leukemia in Trinidad, West Indies.
    Cameron ES; Labastide WB; Wilson V; Charles W; Holder Y; Reid HF
    Leukemia; 1990 Sep; 4(9):615-9. PubMed ID: 2395381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preliminary study of HLA-ABCDR antigens in CML, ANLL, thalassemia and severe aplastic anemia in Thais.
    Chiewsilp P; Sujirachato K; Mongkolsuk T; Junpong S; Jootar S; Hathirat P
    J Med Assoc Thai; 2000 Mar; 83 Suppl 1():S130-6. PubMed ID: 10865419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Argyrophilic nucleolar organizer regions (AgNORs) in relation to p53 and bcl-2 protein expression in leukemia patients.
    Klobusická M; Kusenda J; Babusíková O
    Neoplasma; 2003; 50(6):408-15. PubMed ID: 14689061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low number of complement C3b/C4b receptors (CR1) on erythrocytes from patients with essential mixed cryoglobulinemia, systemic lupus erythematosus and rheumatoid arthritis: relationship with disease activity, anticardiolipin antibodies, complement activation and therapy.
    Corvetta A; Pomponio G; Bencivenga R; Luchetti MM; Spycher M; Spaeth PJ; Danieli G
    J Rheumatol; 1991 Jul; 18(7):1021-5. PubMed ID: 1833542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bone marrow transplantation as therapy in chronic myeloid leukemia].
    Schmeiser T; Arnold R; Wiesneth M; Hertenstein B; Bunjes D; Anger B; Heit W; Heimpel H
    Dtsch Med Wochenschr; 1988 Jan; 113(1):6-10. PubMed ID: 3275532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA and adult T cell leukaemia: HLA-linked genes controlling susceptibility to human T cell leukaemia virus type I.
    Uno H; Kawano K; Matsuoka H; Tsuda K
    Clin Exp Immunol; 1988 Feb; 71(2):211-6. PubMed ID: 2894907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic myeloid leukemia: correlation between purine metabolism enzyme activities and membrane immunophenotype.
    Mesárosová A; Hrivnáková A; Klobusická M; Babusíková O
    Neoplasma; 1995; 42(1):9-14. PubMed ID: 7617076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-A,B and DR antigens in chronic lymphocytic leukaemia.
    Dyer PA; Ridway JC; Flanagan NG
    Dis Markers; 1986 Oct; 4(3):231-7. PubMed ID: 3482989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA CW3 and HLA CW4 have a protective effect on acquisition of chronic myeloid leukemia on Mexican patients.
    Rosas-Cabral A; Irigoyen L; Alvarado L; Vela-Ojeda J; Ayala-Sánchez M; Tripp-Villanueva F; Sánchez E; Gonzalez-Llaven J; Gariglio P
    Rev Invest Clin; 2003; 55(4):423-8. PubMed ID: 14635607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolution of bone marrow fibrosis and stromal antigenic expression in chronic myeloid leukemia on alpha interferon and Ara-C therapy.
    Straetmans N; Ma DD; Nevell DF; Arthur C
    Hematopathol Mol Hematol; 1996; 10(4):213-22. PubMed ID: 9042664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. European results of matched unrelated donor bone marrow transplantation for chronic myeloid leukemia. Impact of HLA class II matching. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
    Devergie A; Apperley JF; Labopin M; Madrigal A; Jacobsen N; Carreras E; Prentice HG; Jouet JP; Kolb HJ; Herstenstein B; Bacigalupo A; Evensen SA; Ljungman P; de Witte T; Reiffers J; Nagler A; Clark RE; Goldman JM; Gratwohl A
    Bone Marrow Transplant; 1997 Jul; 20(1):11-9. PubMed ID: 9232250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of CD34(+) marrow cell dose on outcome of HLA-identical sibling allogeneic bone marrow transplants in patients with chronic myeloid leukaemia.
    Morariu-Zamfir R; Rocha V; Devergie A; Socié G; Ribaud P; Esperou H; Parquet N; Guardiola P; Dal Cortivo L; Bittencourt H; Garnier F; Traineau R; Marolleau JP; Chevret S; Gluckman E
    Bone Marrow Transplant; 2001 Mar; 27(6):575-80. PubMed ID: 11319585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulating capacity of blast cells from patients with chronic myelocytic leukaemia, in blastic crisis in 'one-way' mixed lymphoycte reaction: lack of evidence for T lymphoblastic conversion.
    Han T; Gomez GA; Minowada J
    Immunology; 1978 Aug; 35(2):299-305. PubMed ID: 155646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD117 (c-kit) is a restricted antigen of acute myeloid leukemia and characterizes early differentiative levels of M5 FAB subtype.
    Cascavilla N; Musto P; D'Arena G; Melillo L; Carella AM; Petrilli MP; Sanpaolo G; Carotenuto M
    Haematologica; 1998 May; 83(5):392-7. PubMed ID: 9658721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation.
    Ross GD; Yount WJ; Walport MJ; Winfield JB; Parker CJ; Fuller CR; Taylor RP; Myones BL; Lachmann PJ
    J Immunol; 1985 Sep; 135(3):2005-14. PubMed ID: 4020137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mode of inheritance of decreased C3b receptors on erythrocytes of patients with systemic lupus erythematosus.
    Wilson JG; Wong WW; Schur PH; Fearon DT
    N Engl J Med; 1982 Oct; 307(16):981-6. PubMed ID: 7110302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.